PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.81
ESG score 90-95% of Healthcare median of 61.39. John Neff would demand higher returns to compensate for below-average ESG risk management.
54.80
Environmental score 90-95% of Healthcare median of 58.15. John Neff would demand higher returns to compensate for below-average climate risk management.
57.90
Social score 90-95% of Healthcare median of 63.87. John Neff would demand higher returns to compensate for below-average stakeholder management.
60.72
Governance score near Healthcare median of 63.02. David Dodd would investigate if industry-standard governance adequately protects shareholder interests.